Purpose: To describe a newly established international registry recruiting diverse patients with advanced prostate cancer across academic and community practices to address unmet needs in this population.
Patients And Methods: Initiated in 2017, IRONMAN (International Registry for Men with Advanced Prostate Cancer) is a prospective cohort of patients with advanced prostate cancer. The study will enroll 5,000 patients with metastatic hormone-sensitive prostate cancer (mHSPC) or castration-resistant prostate cancer (CRPC), recruited from Australia, the Bahamas, Barbados, Brazil, Canada, Ireland, Jamaica, Kenya, Nigeria, Norway, South Africa, Spain, Sweden, Switzerland, the United Kingdom, and the United States.
A 36 year old female teacher, presented with a bleeding mass in the introitus, difficult micturition, and dysuria of four months duration. She was a para 3+0, all spontaneous vertex deliveries, her last delivery was in 2001. She was first seen at a private mission hospital in March 2006 where an attempt to excise the mass was made but was abandoned due to bleeding.
View Article and Find Full Text PDFObjectives: To highlight the management of patients with transitional cell carcinoma of the urinary bladder with regards to clinical presentation, treatment and outcome.
Design: A retrospective study.
Setting: Kenyatta National Hospital, Nairobi, Kenya.
Ureterovaginal fistula following laparoscopic assisted vaginal hysterectomy is reported. The injury was missed in the immediate post-operative period. There was delay in urological consultation.
View Article and Find Full Text PDFObjective: To highlight the pattern of patients with transitional cell carcinoma of the urinary bladder with regards to age, sex, ethnic origin and histopathological classification.
Design: A ten year retrospective study.
Setting: Kenyatta National Hospital, Nairobi, Kenya.